The current study offers the experimental evidence that BHGZD may reverse the imbalance of the inflammation-immune system in the development and progression of RA via suppressing the TLR4–mediated NLRP3 inflammasome activation. This evidence concerns the gene NLRP3 and rheumatoid arthritis.